| Title |
Inhaled magnesium sulfate in the treatment of acute asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd003898.pub5 |
| Pubmed ID | |
| Authors |
Colin Powell, Kerry Dwan, Stephen J Milan, Richard Beasley, Rodney Hughes, Jennifer A Knopp-Sihota, Brian H Rowe |
| Abstract |
Asthma exacerbations can be frequent and range in severity from relatively mild to status asthmaticus. The use of magnesium sulfate (MgSO(4)) is one of numerous treatment options available during acute exacerbations. While the efficacy of intravenous MgSO(4) has been demonstrated, little is known of the role of inhaled MgSO(4). |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 42% |
| United Kingdom | 1 | 8% |
| Poland | 1 | 8% |
| Puerto Rico | 1 | 8% |
| Unknown | 4 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 5 | 42% |
| Members of the public | 4 | 33% |
| Science communicators (journalists, bloggers, editors) | 3 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| South Africa | 2 | 1% |
| Chile | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Mexico | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 128 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 15% |
| Researcher | 17 | 13% |
| Student > Ph. D. Student | 15 | 11% |
| Student > Bachelor | 13 | 10% |
| Other | 11 | 8% |
| Other | 35 | 26% |
| Unknown | 25 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 73 | 54% |
| Nursing and Health Professions | 12 | 9% |
| Psychology | 5 | 4% |
| Agricultural and Biological Sciences | 3 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 12 | 9% |
| Unknown | 28 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2017.
All research outputs
#1,924,192
of 22,689,790 outputs
Outputs from Cochrane database of systematic reviews
#4,244
of 12,303 outputs
Outputs of similar age
#19,023
of 278,740 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 192 outputs
Altmetric has tracked 22,689,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,303 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,740 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.